Source: Annual Congress 2004 - Descriptive epidemiology of sarcoidosis, tuberculosis and pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. C. S. Arghir, E. S. Vasiliu, F. R. G. Matusa (Constantza, Romania). The impact of HIV on tuberculosis recrudescence. Eur Respir J 2004; 24: Suppl. 48, 2266

Member's Comments

No comment yet.

Related content which might interest you: The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 On tuberculosis and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020 Year: 2020 Influence of HIV infection on spectrum of extrapulmonary tuberculosis Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 The (in)significance of TB and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020 Year: 2020 Mutual impact of HIV infection on HIV/tuberculosis co-infection Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Effect of time since seroconversion to HIV: rates and risks of recurrent tuberculosis Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Multidrug-resistant TB in children with HIV infection Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 The risk of latent Mycobacterium tuberculosis infection in HIV seropositive children not BCG vaccinated Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019 Year: 2020 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Anti tubercular chemoprophylaxis regimens in HIV seropositives with latent tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002 HIV and multidrug-resistant tuberculosis: overlapping epidemics Source: Eur Respir J 2014; 44: 251-254 Year: 2014 Particularities of tuberculosis at children hospitalized with HIV co-infection Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Latent tuberculosis infection as a cause of tuberculosis disease Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009